COMPANY
YANGZHOU AURISCO PHARMACEUTICAL CO LTD
YANGZHOU AURISCO PHARMACEUTICAL CO LTD: API manufacturer for Semaglutide, Tirzepatide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Semaglutide | DMF 38479, type II, active, submitted 2023-09-11 Regulator FDA drug master file list |
|---|---|
| Semaglutide | DMF 42525, type II, active, submitted 2025-09-26 Regulator FDA drug master file list |
| Tirzepatide | DMF 41816, type II, active, submitted 2025-12-31 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.